Clinical and Molecular Hepatology (Apr 2021)
Negligible risk of hepatocellular carcinoma in chronic hepatitis B patients in immune-tolerant phase: Myth or fact
Abstract
No abstracts available.Keywords
Clinical and Molecular Hepatology (Apr 2021)